Investment Partners Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
MSR
PR
SO
WT
AAS
WAM
RFM
NHFG
RAM
Investment Partners Asset Management's XBI Position: Q2 2026 in Review
Investment Partners Asset Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 3,273 shares worth $518K. The position accounts for 0.29% of the portfolio, ranked #96.
Investment Partners Asset Management first reported a position in XBI in Q4 2023 and has held it in 11 quarters since. 368 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Investment Partners Asset Management held 3,273 shares of State Street SPDR S&P Biotech ETF worth $518K as of Q2 2026.
- Investment Partners Asset Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
- State Street SPDR S&P Biotech ETF made up 0.29% of Investment Partners Asset Management's portfolio in Q2 2026, its #96 holding.
- Investment Partners Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 11 quarters since.
- 368 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Investment Partners Asset Management's 13F filing for Q2 2026, filed 24 Jul 2026.